These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Management of myasthenic crisis: continuous anticholinesterase infusions. Borel CO Crit Care Med; 1993 Jun; 21(6):821-2. PubMed ID: 8504646 [No Abstract] [Full Text] [Related]
7. [Current treatment of myasthenia gravis]. de Assis JL Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156 [No Abstract] [Full Text] [Related]
8. The effect of neostigmine on pyridostigmine bioavailability in myasthenic patients after oral administration. Chan K; Davison SC; Dehghan A; Hyman N Methods Find Exp Clin Pharmacol; 1981; 3(5):291-6. PubMed ID: 7329157 [TBL] [Abstract][Full Text] [Related]
9. [Drug therapy in myasthenia gravis]. Aarli JA Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451 [No Abstract] [Full Text] [Related]
10. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems]. Chesni Y Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291 [No Abstract] [Full Text] [Related]
11. Myasthenia gravis and glycopyrrolate. Marcus E; Wayne F S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713 [No Abstract] [Full Text] [Related]
12. Post-varicella myasthenia gravis. Saha A; Batra P; Vilhekar KY; Chaturvedi P Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of intranasal administration of neostigmine in myasthenic patients. Sghirlanzoni A; Pareyson D; Benvenuti C; Cei G; Cosi V; Lombardi M; Nicora M; Ricciardi R; Cornelio F J Neurol; 1992 Mar; 239(3):165-9. PubMed ID: 1573422 [TBL] [Abstract][Full Text] [Related]